BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 94 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,804 | -90.3% | 1,423,310 | 0.0% | 0.00% | – |
| Q2 2023 | $2,932,019 | -37.8% | 1,423,310 | -0.4% | 0.00% | – |
| Q1 2023 | $4,714,159 | +101.2% | 1,428,533 | 0.0% | 0.00% | – |
| Q4 2022 | $2,342,794 | -62.9% | 1,428,533 | +0.0% | 0.00% | – |
| Q3 2022 | $6,312,000 | +60.2% | 1,427,902 | 0.0% | 0.00% | – |
| Q2 2022 | $3,941,000 | -17.5% | 1,427,902 | +0.5% | 0.00% | – |
| Q1 2022 | $4,775,000 | -16.6% | 1,421,099 | -0.7% | 0.00% | – |
| Q4 2021 | $5,722,000 | +21.0% | 1,430,572 | -0.1% | 0.00% | – |
| Q3 2021 | $4,728,000 | -11.9% | 1,432,419 | +1.4% | 0.00% | – |
| Q2 2021 | $5,369,000 | +5.4% | 1,412,826 | +6.2% | 0.00% | – |
| Q1 2021 | $5,096,000 | -13.0% | 1,330,452 | +2.7% | 0.00% | – |
| Q4 2020 | $5,860,000 | -71.2% | 1,295,088 | +7.8% | 0.00% | -100.0% |
| Q3 2020 | $20,334,000 | +33.8% | 1,201,843 | -11.4% | 0.00% | 0.0% |
| Q2 2020 | $15,201,000 | +169.4% | 1,356,076 | +11.5% | 0.00% | – |
| Q1 2020 | $5,643,000 | +70.8% | 1,216,272 | +57.5% | 0.00% | – |
| Q4 2019 | $3,304,000 | +10.5% | 772,068 | +0.7% | 0.00% | – |
| Q3 2019 | $2,990,000 | +9.4% | 766,868 | +10.9% | 0.00% | – |
| Q2 2019 | $2,733,000 | -9.0% | 691,746 | 0.0% | 0.00% | – |
| Q1 2019 | $3,002,000 | +23.2% | 691,746 | +0.7% | 0.00% | – |
| Q4 2018 | $2,437,000 | -8.1% | 686,606 | -1.1% | 0.00% | – |
| Q3 2018 | $2,652,000 | -2.0% | 694,231 | 0.0% | 0.00% | – |
| Q2 2018 | $2,707,000 | +26.3% | 694,231 | +2.1% | 0.00% | – |
| Q1 2018 | $2,143,000 | -19.5% | 680,031 | +0.2% | 0.00% | – |
| Q4 2017 | $2,661,000 | -4.7% | 678,767 | +0.2% | 0.00% | – |
| Q3 2017 | $2,791,000 | +2.1% | 677,576 | +3.1% | 0.00% | – |
| Q2 2017 | $2,733,000 | +0.6% | 657,101 | +2.8% | 0.00% | – |
| Q1 2017 | $2,717,000 | +84.1% | 639,444 | +10.0% | 0.00% | – |
| Q4 2016 | $1,476,000 | +8.2% | 581,157 | +1.8% | 0.00% | – |
| Q3 2016 | $1,364,000 | +15.0% | 570,767 | +16.0% | 0.00% | – |
| Q2 2016 | $1,186,000 | -8.6% | 491,867 | +1.3% | 0.00% | – |
| Q1 2016 | $1,297,000 | -2.0% | 485,667 | +4.9% | 0.00% | – |
| Q4 2015 | $1,324,000 | -99.2% | 463,040 | -91.5% | 0.00% | -100.0% |
| Q3 2015 | $173,701,000 | +11403.4% | 5,444,014 | +1201.8% | 0.01% | – |
| Q2 2015 | $1,510,000 | +5.0% | 418,197 | +29.4% | 0.00% | – |
| Q1 2015 | $1,438,000 | – | 323,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weaver Consulting Group | 130,000 | $437,000 | 0.21% |
| Ikarian Capital, LLC | 304,161 | $1,022,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 265,000 | $890,000 | 0.12% |
| S.C. Financial Services, Inc. | 15,285 | $51,000 | 0.06% |
| JMAC ENTERPRISES LLC | 45,430 | $153,000 | 0.04% |
| CFO4Life Group, LLC | 12,000 | $40,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 10,839 | $1,329,000 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 29,186 | $98,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 190,403 | $640,000 | 0.00% |